Bimekizumab
3 NDCs across 1 manufacturer|0 Generic,3 Brand
Bimekizumab is used to treat psoriasis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Bimekizumab is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $8016.04 to $8112.59 per ML — a 1% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$8016.04 – $8112.59
per ML
7d Activity
avg +0.1% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing BIMEKIZUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BIMZELX 160 MG/ML AUTOINJECTOR | $8112.5853 per ML | — |
BIMZELX 160 MG/ML AUTOINJECTOR | $8035.0733 per ML | +0.22% |
BIMZELX 320 MG/2 ML AUTOINJECT | $8016.0364 per ML | -0.07% |
Frequently Asked Questions
What is Bimekizumab used to treat?
Bimekizumab is used to treat psoriasis, per the National Library of Medicine's MED-RT classification.
How many Bimekizumab products are on the market?
The Bimekizumab drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Bimekizumab?
NADAC reference prices for Bimekizumab range from $8016.0364 to $8112.5853 per ML — a 1% difference between cheapest and most expensive.
Which manufacturers make Bimekizumab?
1 manufacturer lists Bimekizumab in NADAC. Ranked by number of NDCs, the largest are UCB, Inc. (3).
How has the price of Bimekizumab changed recently?
Over the past 7 days, 1 Bimekizumab NDC rose and 1 fell, with a market-wide average change of +0.1%.